FDA Approved: TUDORZA PRESSAIR — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approved a supplemental application for Tudorza Pressair (aclidinium bromide) submitted by Covis Pharma US, Inc., marking an updated approval for its COPD t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)

Snippet

SUPPL AP for TUDORZA PRESSAIR (ACLIDINIUM BROMIDE)